InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
7
T+90 hit rate
100%
T+90 mean return
+15.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Fitzgerald Joseph Michael, Directeur Exécutif et Président. Insider active across 2 companies, notably Boston Scientific CORP. Aggregated, 53 disclosures have been published. Split: 2 buys · 7 sells. Total volume traded: €17.1m. History available since 6 May 2021. The latest transaction was disclosed on 31 July 2026 (I). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Fitzgerald Joseph Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations53 total
64,198 shares@ US$46.730.0043% mcap7.5% of flowCommon StockSEC:0001225208-26-006881:0
34,898 shares0Common StockSEC:0001225208-26-002134:0
3,462 shares0Common StockSEC:0001225208-26-002015:0
27,880 shares@ US$30.190.30% mcap50.0% of flowClass A Common StockSEC:0002036848-26-000004:0
27,880 shares@ US$30.1949.2% of flowClass A Common StockSEC:0002036848-25-000003:0
690 shares0Common StockSEC:0001225208-25-009225:0
50,000 shares@ US$26.154.3% of flowCommon StockSEC:0001225208-25-008911:0
29,472 shares@ US$99.14149.7% of flowCommon StockSEC:0001225208-25-008911:3
3,600 shares@ US$100.74811.2% of flowCommon StockSEC:0001225208-25-008911:1
16,928 shares@ US$99.76075.6% of flowCommon StockSEC:0001225208-25-008911:2
50,000 shares@ US$26.153.5% of flowCommon StockSEC:0001225208-25-008180:0
50,000 shares@ US$26.153.6% of flowCommon StockSEC:0001225208-25-007716:0
50,000 shares@ US$26.153.8% of flowCommon StockSEC:0001225208-25-006986:0
50,000 shares@ US$26.153.9% of flowCommon StockSEC:0001225208-25-006331:0
56,372 shares@ US$26.154.7% of flowCommon StockSEC:0001225208-25-005721:0
1,700 shares0Common StockSEC:0001225208-25-002471:0
1,000 shares0Common StockSEC:0001225208-25-002169:0
4,362 shares0Common StockSEC:0001225208-25-001870:0
3,462 shares0Common StockSEC:0001225208-25-001791:0
50 shares@ US$90.29190.0% of flowCommon StockSEC:0001225208-25-001683:0
Canonical exit: 3 Mar 2025 (T+90)
13,907 shares0Common StockSEC:0001225208-25-000204:0
1,113 shares0Common StockSEC:0001225208-24-010220:0
11,236 shares0Common StockSEC:0001225208-24-010220:1
57,618 shares@ US$24.985.0% of flowCommon StockSEC:0001225208-24-009233:1
59,021 shares@ US$17.263.5% of flowCommon StockSEC:0001225208-24-009233:0
25 of 53 declarations
About Fitzgerald Joseph Michael
Fitzgerald Joseph Michael is Chief Executive Officer and Chairman. He has 50 filings in total. In the 50 most recent filings available, the period runs from 2016-01-05 to 2026-02-18, with EUR 4,299 of buys and EUR 17,050,051 of sells, and the most common transaction nature is option exercise. His filings concern Boston Scientific CORP and Chain Bridge Bancorp INC.
